Dr. Adam Vogel
Professor, Centre for Neuroscience of Speech
The University of Melbourne
Professor Adam Vogel is Professor of Speech Neuroscience at The University of Melbourne and an Australian Research Council Future Fellow. His research focuses on enhancing communication and swallowing outcomes in individuals with progressive and acquired neurological disorders.
Adam earned his PhD in behavioural neuroscience from The University of Melbourne, following undergraduate degrees in psychology and speech science from The University of Queensland. He is also a Humboldt Fellow at the Hertie Institute for Clinical Brain Research in Tübingen, Germany.
In addition to his academic role, Adam serves as CEO at Redenlab Ltd., a neuroscience technology company specialising in speech and language biometrics to improve decision-making in clinical trials. Redenlab's digital speech platform provides objective measurement and analysis of communication, supporting pharmaceutical companies across more than 25 countries and 300 international sites.
SESSIONS
Day 2
1:50
Early speech changes as clinical clues for cognitive decline
How can subtle shifts in speech provide some of the earliest indicators of neurodegeneration, long before functional decline becomes visible?
Gain insight into how reduced speech complexity, slower speech rate and conversational changes can support earlier recognition of cognitive impairment, complement traditional assessments, and guide more confident, person-centred clinical decision-making in aged care
Dr. Adam Vogel, Professor, Centre for Neuroscience of Speech, The University of Melbourne